Overview

U87 CART in Treatment of Advanced Pancreatic Cancer

Status:
Recruiting
Trial end date:
2025-10-08
Target enrollment:
Participant gender:
Summary
This is a single center, open-label, phase 1 study to evaluate the safety and efficacy of U87 CART in treating advanced Pancreatic Cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Collaborator:
Shanghai 10th People's Hospital